Cargando…
Population pharmacokinetics of tigecycline in critically ill patients
Objective: In critically ill patients, the change of pathophysiological status may affect the pharmacokinetic (PK) process of drugs. The purpose of this study was to develop a PK model for tigecycline in critically ill patients, identify the factors influencing the PK and optimiz dosing regimens. Me...
Autores principales: | Luo, Xiangru, Wang, Shiyi, Li, Dong, Wen, Jun, Sun, Na, Fan, Guangjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040605/ https://www.ncbi.nlm.nih.gov/pubmed/36992827 http://dx.doi.org/10.3389/fphar.2023.1083464 |
Ejemplares similares
-
Population Pharmacokinetics of High-Dose Tigecycline in Patients with Sepsis or Septic Shock
por: Borsuk-De Moor, Agnieszka, et al.
Publicado: (2018) -
The pharmacokinetics of tigecycline in critically ill adult patients undergoing CVVHD
por: Rypulak, E, et al.
Publicado: (2015) -
Population Pharmacokinetics of Colistin Sulfate in Critically Ill Patients: Exposure and Clinical Efficacy
por: Yu, Xu-ben, et al.
Publicado: (2022) -
Population pharmacokinetic analysis and dosing regimen optimization of teicoplanin in critically ill patients with sepsis
por: Chen, Chao‐Yang, et al.
Publicado: (2023) -
Population pharmacokinetic analysis and dosing optimization of polymyxin B in critically ill patients
por: Liang, Danhong, et al.
Publicado: (2023)